$313 Thousand is the total value of DCVC Bio GP, LLC's 1 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
ABCL | Sell | AbCellera Biologics, Inc. | $313,000 | -99.6% | 29,411 | -99.6% | 100.00% | 0.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
AbCellera Biologics, Inc. | 4 | Q3 2022 | 100.0% |
View DCVC Bio GP, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-11-14 |
13F-HR | 2022-02-14 |
4 | 2021-06-22 |
3/A | 2020-12-17 |
4 | 2020-12-17 |
3 | 2020-12-11 |
View DCVC Bio GP, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.